In humans, amino acid changes in KLF11 are associated with maturity onset diabetes of the young type VII, whereas complete inactivation of this pathway by the -331-insulin mutation causes neonatal diabetes mellitus. The gene discussed is KLF11; the disease is type 2 diabetes mellitus.